Argenx
ARGX
#499
Rank
โ‚น4.822 T
Marketcap
โ‚น77,162
Share price
-1.20%
Change (1 day)
55.76%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2026 (TTM): โ‚น134.91 Billion

According to Argenx 's latest financial reports the company's current earnings are โ‚น4.66 Billion. In 2025 the company made an earning of โ‚น122.30 Billion, an increase over its 2024 earnings that were of โ‚น8.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น134.91 B10.31%
2025 โ‚น122.30 B1400.64%
2024 โ‚น8.15 B-127.97%
2023 -โ‚น29.14 Billion-58.25%
2022 -โ‚น69.79 Billion80.17%
2021 -โ‚น38.74 Billion
2019 -โ‚น19.03 Billion124.86%
2018 -โ‚น8.47 Billion131.81%
2017 -โ‚น3.65 Billion
2015 -โ‚น1.77 Billion
2013 -โ‚น1.07 Billion